Skip to content
MARKETS / NYSE / MIR
NYSE · MEASURING & CONTROLLING DEVICES, NEC · LARGE CAP

Mirion Technologies, Inc. MIR

8 fiscal years on record · USD · FY2025 reported · SEC filings only
$925.4M
▲ 7.5% YoY
$28.8M
$106.9M
▲ 112.5% YoY
In brief

What this company does

Mirion provides products, services and software for radiation safety, measurement and analysis applications across nuclear power facilities, laboratories, research and other industrial markets, and for cancer care delivery, medical diagnostics and practitioner safety. It is headquartered in Atlanta, Georgia, and has operations in Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, Japan, and South Korea. As of December 31, 2025, it employed 3,281 full-time and part-time employees. For the fiscal years ended December 31, 2025, 2024 and 2023, no customer accounted for greater than 5% of its consolidated revenue, and its top ten customers represented approximately 19%, 17% and 19% of its consolidated revenue, respectively. Mirion is comprised of two reporting segments, Nuclear & Safety, formerly named Technologies, and Medical. For more than 60 years, Mirion and its predecessor companies have provided products, services and software related to ionizing radiation.

Written from the business description in Mirion Technologies, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 19 February 2026. Every sentence was checked against that document before publication.

Growth
USD 925.4M
Revenue, FY2025 · full 8-year series below
Revenue $M Net income $M
FY2025 · Revenue 925.4 · Net income 28.8
400M800M-100M-200M20182019202020212022202320242025
Compound annual growth
+8.8%
+8.6%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +8.6% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
3 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 5.6% · Net 3.2%
2%4%6%-20%-40%20182019202020212022202320242025
ROE
FY2025 · ROE 1.7%
-1000000%-2000000%20182019202020212022202320242025

Each USD of equity produced 2 cents of profit this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 106.9
40M80M20182019202020212022202320242025
Net buybacks $M Dividends $M
FY2025 · Dividends — · Net buybacks -375.4
-200M20202022202320242025

Total assetsUSD 3.6B
EquityUSD 1.9B
CashUSD 412.3M
Gross debtUSD 444.7M
Net debtUSD 32.4M
DepositsUSD 19.5M

Net debt stands at 2% of equity.

The 8-year record
8 fiscal years
Every figure from documents filed with the SEC · USD

The share count changed between 2020 and 2022, but the exact year can't be marked here — the underlying count wasn't on file for every year in that stretch.

row low → row highnegative
Metric 20252024202320222021202020192018
Revenue $B0.90.90.80.7·0.60.50.4
Operating income $B0.10.0−0.0−0.3·0.00.00.0
EBITDA $B0.20.20.1−0.1·0.10.1·
Income tax $B0.00.0−0.0−0.0·−0.0−0.0−0.0
Net income $B0.0−0.0−0.1−0.3−0.2−0.2−0.1−0.1
Free cash flow $B0.10.10.10.0·0.00.0−0.0
EPS, diluted $0.11−0.18−0.49−1.53·−24.18−18.45−19.36
Dividend / sh $········
Payout %········
ROE %1.7−2.4−6.7−17.9−37.2··−2592986.2
Shares out B··0.02·0.020.02··

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 36 reconciliationsAUDITED

Reconciled in 8 of 19 fiscal years. 59 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityMeasuring & Controlling Devices, NEC
Listed onNYSE
Incorporated innot stated in the filings
Fiscal year endsDecember 31
Data on record since2018

Share this section

Download image